These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 16566449

  • 1. Insect cells as a new substrate for vaccine production.
    Dalemans W.
    Dev Biol (Basel); 2006; 123():235-41; discussion 265-6. PubMed ID: 16566449
    [Abstract] [Full Text] [Related]

  • 2. Safety assessment of Madin Darby canine kidney cells as vaccine substrate.
    Medema JK, Meijer J, Kersten AJ, Horton R.
    Dev Biol (Basel); 2006; 123():243-50; discussion 265-6. PubMed ID: 16566450
    [Abstract] [Full Text] [Related]

  • 3. Ensuring the safety of vaccine cell substrates by massively parallel sequencing of the transcriptome.
    Onions D, Côté C, Love B, Toms B, Koduri S, Armstrong A, Chang A, Kolman J.
    Vaccine; 2011 Sep 22; 29(41):7117-21. PubMed ID: 21651935
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Detection of adventitious viruses in biologicals--a rare occurrence.
    Nims RW.
    Dev Biol (Basel); 2006 Sep 22; 123():153-64; discussion 183-97. PubMed ID: 16566443
    [Abstract] [Full Text] [Related]

  • 6. FluBlok, a next generation influenza vaccine manufactured in insect cells.
    Cox MM, Hollister JR.
    Biologicals; 2009 Jun 22; 37(3):182-9. PubMed ID: 19297194
    [Abstract] [Full Text] [Related]

  • 7. Issues of biological assays for viral vaccines.
    Lee CK.
    Dev Biol Stand; 1996 Jun 22; 88():41-7. PubMed ID: 9119161
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Karyology and tumorigenicity testing requirements: past, present and future.
    Petricciani JC, Horaud FN.
    Dev Biol Stand; 1998 Jun 22; 93():5-13. PubMed ID: 9737371
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Large-scale propagation of insect cells.
    Vaughn JL, Weiss SA.
    Bioprocess Technol; 1990 Jun 22; 10():597-618. PubMed ID: 1367072
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Scope and practicality of in vivo testing for adventitious agents.
    Whiteman MD.
    Dev Biol (Basel); 2006 Jun 22; 123():147-52; discussion 183-97. PubMed ID: 16566442
    [Abstract] [Full Text] [Related]

  • 15. Quality of biotechnological products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. ICH Harmonised Tripartite Guideline.
    Dev Biol Stand; 1998 Jun 22; 93():177-201. PubMed ID: 9737396
    [No Abstract] [Full Text] [Related]

  • 16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials.
    Food Chem Toxicol; 2008 Mar 22; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [Abstract] [Full Text] [Related]

  • 17. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.
    Barrett PN, Mundt W, Kistner O, Howard MK.
    Expert Rev Vaccines; 2009 May 22; 8(5):607-18. PubMed ID: 19397417
    [Abstract] [Full Text] [Related]

  • 18. Issues related to harmonization of testing requirements for viral safety.
    Hayakawa T.
    Dev Biol Stand; 1996 May 22; 88():15-8. PubMed ID: 9119129
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media.
    Merten OW.
    Dev Biol (Basel); 2002 May 22; 111():233-57. PubMed ID: 12678248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.